Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1981 Jan;67(1):247–259. doi: 10.1172/JCI110020

Interactions between Antibiotics and Human Neutrophils in the Killing of Staphylococci

STUDIES WITH NORMAL AND CYTOCHALASIN B-TREATED CELLS

Richard K Root 1,2, Raul Isturiz 1,2, Abdolghader Molavi 1,2, Julia A Metcalf 1,2, Harry L Malech 1,2
PMCID: PMC371594  PMID: 7451652

Abstract

Normal and antibiotic-pretreated staphylococci were incubated with human neutrophils to determine the interactions between cells and antimicrobials in the killing of the organisms. Staphylococcus aureus 502A pretreated during log-phase growth with subinhibitory (¼ minimum inhibiting concentration) (MIC) concentrations of penicillin G were more susceptible to killing by normal neutrophils than untreated bacteria (intracellular survival 0.17±0.04 vs. 1.5±0.38%, mean±SEM, respectively, at 35 min in 14 experiments; P < 0.01 by t test). Furthermore, this enhanced susceptibility to killing was observed even when phagosome formation was inhibited by cytochalasin B (65.6±4.6% pencillintreated vs. 30.5±4.5% untreated killed at 30 min in 14 experiments, P < 0.001). Pretreatment of S. aureus with vancomycin similarly enhanced susceptibility to killing by cytochalasin B-treated polymorphonuclear leukocytes (PMN), whereas pretreatment with gentamicin did not.

The enchancement of killing by pretreatment with cell wall-active antibiotics was present in a dose-response fashion to 1/16th the MIC. It required specific antimicrobial activity; i.e., penicillin activity was inhibited by penicillinase or by incubation with bacteria at 4°C. It also required active cellular metabolism and intact neutrophils. For antibiotic-pretreated bacteria to be killed by normal and cytochalasin B-treated cells, phagocytosis or binding to the cells was essential via a serum opsonindependent mechanism. In experiments with the cytochalasin B-treated cells, all bound penicillin-treated bacteria were killed vs. only a fraction (70%) of the bound untreated bacteria. Penicillin in 10 times the MIC had no direct effects on PMN phagocytic, metabolic, or microbicidal functions against a nonsusceptible organism, Candida albicans.

The results indicate a cooperative effect between cell wall-active antibiotics at low concentrations and human PMN in the killing of staphylococci. The model establishes conditions for the study of the mechanisms involved in the cooperation of these bactericidal systems.

Full text

PDF
247

Images in this article

249Image
on p.249
256Image
on p.256

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alexander J. W., Good R. A. Effect of antibiotics on the bactericidal activity of human leukocytes. J Lab Clin Med. 1968 Jun;71(6):971–983. [PubMed] [Google Scholar]
  2. Alexander J. W., Windhorst D. B., Good R. A. Improved tests for the evaluation of neutrophil function in human disease. J Lab Clin Med. 1968 Jul;72(1):136–148. [PubMed] [Google Scholar]
  3. Cook F. V., Farrar W. E., Jr Vancomycin revisited. Ann Intern Med. 1978 Jun;88(6):813–818. doi: 10.7326/0003-4819-88-6-813. [DOI] [PubMed] [Google Scholar]
  4. Friedman H., Warren G. H. Enhanced susceptibility of penicillin-resistant staphylococci to phagocytosis after in vitro incubation with low doses of nafcillin. Proc Soc Exp Biol Med. 1974 Jul;146(3):707–711. doi: 10.3181/00379727-146-38177. [DOI] [PubMed] [Google Scholar]
  5. Greenwood D. Differentiation of mechanisms responsible for inoculum effects in the response of Escherichia coli to a variety of antibiotics. J Antimicrob Chemother. 1976 Mar;2(1):87–95. doi: 10.1093/jac/2.1.87. [DOI] [PubMed] [Google Scholar]
  6. Hahn F. E., Sarre S. G. Mechanism of action of gentamicin. J Infect Dis. 1969 Apr-May;119(4):364–369. doi: 10.1093/infdis/119.4-5.364. [DOI] [PubMed] [Google Scholar]
  7. Hakenbeck R., Waks S., Tomasz A. Characterization of cell wall polymers secreted into the growth medium of lysis-defective pneumococci during treatment with penicillin and other inhibitors of cell wall synthesis. Antimicrob Agents Chemother. 1978 Feb;13(2):302–311. doi: 10.1128/aac.13.2.302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Harris M. B., Djerassi I., Schwartz E., Root R. K. Polymorphonuclear leukocytes prepared by continuous-flow filtration leukapheresis: viability and function. Blood. 1974 Nov;44(5):707–713. [PubMed] [Google Scholar]
  9. Khan A. J., Evans H. E., Glass L., Khan P., Chang C. T., Nair S. R. Abnormal neutrophil chemotaxis and random migration induced by aminoglycoside antibiotics. J Lab Clin Med. 1979 Feb;93(2):295–300. [PubMed] [Google Scholar]
  10. Klebanoff S. J. Antimicrobial mechanisms in neutrophilic polymorphonuclear leukocytes. Semin Hematol. 1975 Apr;12(2):117–142. [PubMed] [Google Scholar]
  11. Leijh P. C., van den Barselaar M. T., van Zwet T. L., Dubbeldeman-Rempt I., van Furth R. Kinetics of phagocytosis of Staphylococcus aureus and Escherichia coli by human granulocytes. Immunology. 1979 Jun;37(2):453–465. [PMC free article] [PubMed] [Google Scholar]
  12. Lorian V., Atkinson B. Effects of subinhibitory concentrations of antibiotics on cross walls of cocci. Antimicrob Agents Chemother. 1976 Jun;9(6):1043–1055. doi: 10.1128/aac.9.6.1043. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Lorian V. Some effect of subinbilitory concentrations of penicillin on the structure and division of staphylococci. Antimicrob Agents Chemother. 1975 Jun;7(6):864–867. doi: 10.1128/aac.7.6.864. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Malawista S. E., Gee J. B., Bensch K. G. Cytochalasin B reversibly inhibits phagocytosis: functional, metabolic, and ultrastructural effects in human blood leukocytes and rabbit alveolar macrophages. Yale J Biol Med. 1971 Dec;44(3):286–300. [PMC free article] [PubMed] [Google Scholar]
  15. Mandell G. L. Interaction of intraleukocytic bacteria and antibiotics. J Clin Invest. 1973 Jul;52(7):1673–1679. doi: 10.1172/JCI107348. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Martin R. R., Warr G. A., Couch R. B., Yeager H., Knight V. Effects of tetracycline on leukotaxis. J Infect Dis. 1974 Feb;129(2):110–116. doi: 10.1093/infdis/129.2.110. [DOI] [PubMed] [Google Scholar]
  17. Repine J. E., White J. G., Clawson C. C., Holmes B. M. Effects of phorbol myristate acetate on the metabolism and ultrastructure of neutrophils in chronic granulomatous disease. J Clin Invest. 1974 Jul;54(1):83–90. doi: 10.1172/JCI107752. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Root R. K., Metcalf J. A. H2O2 release from human granulocytes during phagocytosis. Relationship to superoxide anion formation and cellular catabolism of H2O2: studies with normal and cytochalasin B-treated cells. J Clin Invest. 1977 Dec;60(6):1266–1279. doi: 10.1172/JCI108886. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Root R. K., Metcalf J., Oshino N., Chance B. H2O2 release from human granulocytes during phagocytosis. I. Documentation, quantitation, and some regulating factors. J Clin Invest. 1975 May;55(5):945–955. doi: 10.1172/JCI108024. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Root R. K., Rosenthal A. S., Balestra D. J. Abnormal bactericidal, metabolic, and lysosomal functions of Chediak-Higashi Syndrome leukocytes. J Clin Invest. 1972 Mar;51(3):649–665. doi: 10.1172/JCI106854. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Root R. K., Stossel T. P. Myeloperoxidase-mediated iodination by granulocytes. Intracellular site of operation and some regulating factors. J Clin Invest. 1974 May;53(5):1207–1215. doi: 10.1172/JCI107667. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. SCHINDLER C. A., SCHUHARDT V. T. PURIFICATION AND PROPERTIES OF LYSOSTAPHIN--A LYTIC AGENT FOR STAPHYLOCOCCUS AUREUS. Biochim Biophys Acta. 1965 Feb 15;97:242–250. doi: 10.1016/0304-4165(65)90088-7. [DOI] [PubMed] [Google Scholar]
  23. Schaffner W., Melly M. A., Hash J. H., Koenig M. G. Lysostaphin: an enzymatic approach to staphylococcal disease. I. In vitro studies. Yale J Biol Med. 1967 Feb;39(4):215–229. [PMC free article] [PubMed] [Google Scholar]
  24. Seklecki M. M., Quintiliani R., Maderazo E. G. Aminoglycoside antibiotics moderately impair granulocyte function. Antimicrob Agents Chemother. 1978 Mar;13(3):552–554. doi: 10.1128/aac.13.3.552. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Shah P. M., Heetderks G., Stille W. Activity of amikacin at sub-inhibitory levels. J Antimicrob Chemother. 1976 Mar;2(1):97–100. doi: 10.1093/jac/2.1.97. [DOI] [PubMed] [Google Scholar]
  26. Silverstein S. C., Steinman R. M., Cohn Z. A. Endocytosis. Annu Rev Biochem. 1977;46:669–722. doi: 10.1146/annurev.bi.46.070177.003321. [DOI] [PubMed] [Google Scholar]
  27. Tomasz A. The mechanism of the irreversible antimicrobial effects of penicillins: how the beta-lactam antibiotics kill and lyse bacteria. Annu Rev Microbiol. 1979;33:113–137. doi: 10.1146/annurev.mi.33.100179.000553. [DOI] [PubMed] [Google Scholar]
  28. Verhoef J., Peterson P. K., Quie P. G. Human polymorphonuclear leucocyte receptors for staphylococcal opsonins. Immunology. 1977 Aug;33(2):231–239. [PMC free article] [PubMed] [Google Scholar]
  29. Washington J. A., 2nd The effects and significance of subminimal inhibitory concentrations of antibiotics. Rev Infect Dis. 1979 Sep-Oct;1(5):781–786. doi: 10.1093/clinids/1.5.781. [DOI] [PubMed] [Google Scholar]
  30. Zak O., Kradolfer F. Effects of subminimal inhibitory concentrations of antibiotics in experimental infections. Rev Infect Dis. 1979 Sep-Oct;1(5):862–879. doi: 10.1093/clinids/1.5.862. [DOI] [PubMed] [Google Scholar]
  31. Zigmond S. H., Hirsch J. G. Effects of cytochalasin B on polymorphonuclear leucocyte locomotion, phagocytosis and glycolysis. Exp Cell Res. 1972 Aug;73(2):383–393. doi: 10.1016/0014-4827(72)90062-6. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES